How to optimize lipid-lowering therapy for patients with higher CV risk?

16 Jan 2023
Dr. Chiu-Lai Fu
Dr. Chiu-Lai FuSpecialist in Cardiology; Private Practice, Hong Kong
Dr. Chiu-Lai Fu
Dr. Chiu-Lai Fu Specialist in Cardiology; Private Practice, Hong Kong
How to optimize lipid-lowering therapy for patients with higher CV risk?
Dr Chiu-Lai Fu reviews international guideline recommendations on LDL-C goals and lipid-modifying therapy for patients at high or very high CV risk. Advantages of ezetimibe/statin combination therapy are discussed based on clinical studies and her experience.
This video is made possible through an education grant from the industry.
HK-ATO-110039 JAN/2023